Business
Posting of Annual Report and
Posting of Annual Report and.
About this update from Genedrive Plc
[{"type":"text","content":"\n RNS Number : 9564B Epistem Holdings plc 04 November 2009 \n\n\n\nFor release: 4 November 2009\n\n\n\nEpistem Plc \n(\"Epistem\" or the \"Company\")\n\nPosting of Annual Report and Accounts\n\nEpistem Plc (LSE: EHP), the rapidly growing UK biotechnology company with adult epithelial stem cell expertise in oncology, gastrointestinal and dermatological diseases, confirms that its Annual Report and Accounts for the year ended 30 June 2009 and notice of AGM were posted to shareholders on 2 November 2009. \n\nAn electronic copy of the Annual Report and Accounts is available on the Investor Centre section of the Company's website, www.epistem.co.uk.\n\n\nFor further details, please contact:\n\nEpistem Plc\nMatthew Walls CEO +44 (0) 161 606 7258\nJohn Rylands CFO\n\nPiper Jaffray Ltd.\nNeil Mackison, Graeme Smethurst +44 (0) 0203 142 8700\nCorporate Broking: Jamie Adams\n\nMike Wort / Anna Dunphy +44 (0) 207 861 3838\nDe Facto Communications\n\n\nAbout Epistem:\n\nEpistem is a biotechnology company commercialising its expertise in epithelial stem cells in the areas of oncology, gastrointestinal diseases, dermatology and ageing. Epistem provides specialised pre-clinical efficacy testing, biomarker services and develops proprietary novel therapeutics for partnership and development with drug development companies.\n\n\n\n\n\n\n\n\n\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END ACSZGMGMDDRGLZM \n ","length":3795,"tagName":"div"}]